




版權說明:本文檔由用戶提供并上傳,收益歸屬內容提供方,若內容存在侵權,請進行舉報或認領
文檔簡介
1、老年高血壓患者的治療ACC in ChinaHypertension, Prevention and Lipids (HPL) Jiguang WANG, MD, PhDShanghai Institute of Hypertension, Ruijin Hospital, Shanghai, China老年高血壓患者的治療Management of hypertension in the elderly Jiguang WANG, MD, PhDShanghai Institute of Hypertension, Ruijin Hospital, Shanghai, China老年高血壓患
2、者的治療nSize of the problem: hypertensionnCareful selection of antihypertensive drugs to potentiate the huge benefit and to avoid the potential harmnRoadmap to control blood pressure in resistant hypertensive patients老年高血壓患者的治療Awareness, treatment and control rates of hypertension in ChinaPrevalenceNum
3、ber of patientsAwareness TreatedControlled 1991 (15 y)11.394 million26.645.5% (12.1)23.1% (2.8)2002 (18 y)18.8160 million30.281.8% (24.7)25.0% (6.1)2002 (60 y)49.170 million37.696.3% (36.2)24.1% (7.6)Chin J Hypertens 1995;3(suppl):14 -18; Li Liming, et al. ChinJ E pidemiol 2005;26:,478-484.老年高血壓患者的治
4、療nSize of the problem: hypertensionnCareful selection of antihypertensive drugs to potentiate the huge benefit and to avoid the potential harmnRoadmap to control blood pressure in resistant hypertensive patients老年高血壓患者的治療Relative risk reductions by antihypertensive treatment in early trialsProgressi
5、on to severe HTCHFStrokeCHDTotal mortalityCV mortality-94*-53%*-40%*-16%*-13%-21%*P0.05Collins R et al. Br Med Bull 1994;50:272-298.老年高血壓患者的治療BPLTTC. Lancet 2003;362:1527-45.0-5-10-15-20-25-30StrokeCHDCHFTotal mortality -23%-15%-16%-14%4/3 mmHgN20 888Major CV events -15%Relative risk reductions by a
6、ntihypertensive treatment in recent trials老年高血壓患者的治療指南推薦指南推薦o利尿劑利尿劑o 阻滯劑阻滯劑o鈣離子拮抗劑鈣離子拮抗劑o轉換酶抑制劑轉換酶抑制劑o血管緊張素受體拮抗劑血管緊張素受體拮抗劑J Hypertens 2007;25:1105-87.老年高血壓患者的治療INTERMAP: Urinary electrolytes in menZhou BF et al. J Hum Hypertens 2003;17:623630. JapanChinaUKUSAUrinary Na(mg/day)4843563337024202Urinary
7、 Na(mmol/day)211245161183Urinary K(mg/day)1920150629122512Urinary K(mmol/day)49.238.674.764.4Urinary Na/K(mmol/mmol)4.56.82.33.1老年高血壓患者的治療INTERMAP: Urinary electrolytes in womenZhou BF et al. J Hum Hypertens 2003;17:623630.JapanChinaUKUSAUrinary Na(mg/day)4278483929293272Urinary Na(mmol/day)18621012
8、7142Urinary K(mg/day)1891147523781982Urinary K(mmol/day)48.537.961.050.8Urinary Na/K(mmol/mmol)4.16.02.23.1老年高血壓患者的治療HYVET: Serum concentrations of cholesterol, sodium and potassiumLiu LS et al. Chin Med J 2008; 121:1509-1512.MenWomen Characteristic (mmol/L)China Other countriesChina Other countries
9、 Total cholesterol4.691.05.451.15.021.15.601.1HDL cholesterol 1.370.36 1.290.391.430.361.330.43Sodium 1404.1 1424.11404.1 1424.3Potassium 4.250.47 4.420.404.260.494.380.40老年高血壓患者的治療SHEP: New-onset diabetes mellitusShafi T et al. Hypertension 2008;52:1022-9.45% per 0.5 mmol/L in K+老年高血壓患者的治療nSize of
10、the problem: hypertensionnCareful selection of antihypertensive drugs to potentiate the huge benefit and to avoid the potential harmnRoadmap to control blood pressure in resistant hypertensive patients老年高血壓患者的治療Hypertension 2008老年高血壓患者的治療Pharmacologic recommendations for the treatment of resistant h
11、ypertension (1) Use of a long-acting thiazide diuretic, preferably chlorthalidone Combine agents with different mechanisms of action Recommended triple regimen of - ACE inhibitor or ARB - Calcium channel blocker- Thiazide diuretic老年高血壓患者的治療oConsider addition of mineralocorticoid receptor antagonist.
12、 oUse of loop diuretic may be necessary in patients with CKD (creatinine clearance 30 mL/min). Pharmacologic recommendations for the treatment of resistant hypertension (2)老年高血壓患者的治療Number No. drugs 2 drugsALLHAT42,4241.840%ANBP26083 2.050%ASCOT19,2572.378%CONVINCE16,6021.840%INVEST22,5763.085%LIFE9
13、1932.046%VALUE15,2452.054%Number of drugs in recent large HT trialsAchieved 135/76147/82136/77136/79131/76144/81138/78老年高血壓患者的治療Catheter-Based Renal Sympathetic Denervationfor the Management of Resistant HypertensionHenry Krum MBBS PhD FRACPCentre of Cardiovascular Research & Education in Therapeuti
14、cs, Monash University/Alfred Hospital;Alfred Heart Centre, The Alfred Hospital, Melbourne, Australia老年高血壓患者的治療Treatments 老年高血壓患者的治療Catheter-Based Renal Sympathetic Denervationfor the Management of Resistant HypertensionHenry Krum MBBS PhD FRACPCentre of Cardiovascular Research & Education in Therape
15、utics, Monash University/Alfred Hospital;Alfred Heart Centre, The Alfred Hospital, Melbourne, Australia老年高血壓患者的治療Results: Blood Pressure Reduction 87% had a reductionin SBP 10 mmHgP0.001 except for DBP at 12 months (P=0.02)老年高血壓患者的治療Conclusions Therapeutic renal sympathetic denervation produced pred
16、ictable, significant, and sustained reductions in BP in patients with resistant hypertension. The brief and simple procedure was performed without significant complications to either the renal artery or the kidney. Results appear both to confirm the important role of renal sympathetic nerves in resi
17、stant hypertension and to suggest that renal sympathetic denervation could be of therapeutic benefit in this patient population. Prospective randomized clinical trials examining the treatment of hypertension are beginning in 2009, and trials in heart failure and chronic kidney disease are anticipate
18、d. 老年高血壓患者的治療n因為知曉率低、用藥后血壓控制率低,我國因為知曉率低、用藥后血壓控制率低,我國90%以上的高血壓患以上的高血壓患者的血壓未得到有效控制者的血壓未得到有效控制(140/90 mm Hg),在廣大農村該比例,在廣大農村該比例甚至高達甚至高達96.5%。因此,必需大幅度提高高血壓檢出率與治療控。因此,必需大幅度提高高血壓檢出率與治療控制率。制率。n指南推薦使用的指南推薦使用的5大類降壓藥物均可在大類降壓藥物均可在50%以上的患者中發揮降以上的患者中發揮降壓作用。在關注降壓達標的同時,應盡可能減少降壓藥物的不良壓作用。在關注降壓達標的同時,應盡可能減少降壓藥物的不良反應,降低降壓治療的代價。反應,降低降壓治療的代價。n聯合降壓治療,特別聯合使用聯合降
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經權益所有人同意不得將文件中的內容挪作商業或盈利用途。
- 5. 人人文庫網僅提供信息存儲空間,僅對用戶上傳內容的表現方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容,請與我們聯系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 倉儲文員崗位面試問題及答案
- 采購總監崗位面試問題及答案
- 2025屆廣東省廣州市廣東二師番禺附中化學高一下期末檢測模擬試題含解析
- 2025屆陜西省銅川市高二化學第二學期期末達標檢測試題含解析
- 農業監督項目管理辦法
- 園區綠化養護管理辦法
- 醫保總額付費管理辦法
- 保健食品銷售管理辦法
- 復合地層盾構掘進管線保護與地層加固優化方案研究
- 家驢MRFs基因家族的全基因組鑒定與轉錄組學分析探究
- 2023-2024年全科醫學(正高)考試高頻題庫(歷年考點版)帶答案解析
- YY/T 0870.2-2019醫療器械遺傳毒性試驗第2部分:體外哺乳動物細胞染色體畸變試驗
- JJG 40-2011X射線探傷機
- GB/T 8923.1-2011涂覆涂料前鋼材表面處理表面清潔度的目視評定第1部分:未涂覆過的鋼材表面和全面清除原有涂層后的鋼材表面的銹蝕等級和處理等級
- GB/T 7778-2017制冷劑編號方法和安全性分類
- GB/T 4169.4-2006塑料注射模零件第4部分:帶頭導柱
- 天津2023年天津銀行信息技術崗招聘黑鉆模擬III試題3套含答案詳解
- 01-TOC約束理論(瓶頸管理)八講 作業
- 《國家學生體質健康標準》登記卡(高中樣表)
- 靜脈炎的分級及護理課件
- 折讓證明模板
評論
0/150
提交評論